Nikos Pantazis

Summary

Affiliation: University of Athens
Country: Greece

Publications

  1. ncbi Changes in T cell receptor excision DNA circle (TREC) levels in HIV type 1-infected subjects pre- and post-highly active antiretroviral therapy
    Giota Touloumi
    Department of Hygiene and Epidemiology, Athens University Medical School, Athens, Greece
    AIDS Res Hum Retroviruses 20:47-54. 2004
  2. ncbi Differences in HIV RNA levels before the initiation of antiretroviral therapy among 1864 individuals with known HIV-1 seroconversion dates
    Giota Touloumi
    Department of Hygiene and Epidemiology, Athens Univerity Medical School, Greece
    AIDS 18:1697-705. 2004
  3. ncbi Highly active antiretroviral therapy interruption: predictors and virological and immunologic consequences
    Giota Touloumi
    Athens University Medical School, Athens, Greece
    J Acquir Immune Defic Syndr 42:554-61. 2006
  4. ncbi Differences in HIV natural history among African and non-African seroconverters in Europe and seroconverters in sub-Saharan Africa
    Nikos Pantazis
    Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School, Athens, Greece
    PLoS ONE 7:e32369. 2012
  5. ncbi The effect of antiretroviral treatment of different durations in primary HIV infection
    Nikos Pantazis
    Department of Hygiene, Epidemiology and Medical Statistics, Athens University Medical School, Athens, Greece
    AIDS 22:2441-50. 2008
  6. ncbi Robustness of a parametric model for informatively censored bivariate longitudinal data under misspecification of its distributional assumptions: A simulation study
    Nikos Pantazis
    Department of Hygiene and Epidemiology, Athens University Medical School, Athens, Greece
    Stat Med 26:5473-85. 2007
  7. ncbi Cellular HIV-1 DNA load predicts HIV-RNA rebound and the outcome of highly active antiretroviral therapy
    Angelos E Hatzakis
    Department of Hygiene and Epidemiology, Athens University Medical School, Athens, Greece
    AIDS 18:2261-7. 2004
  8. ncbi Rates and determinants of virologic and immunological response to HAART resumption after treatment interruption in HIV-1 clinical practice
    Giota Touloumi
    Department of Hygiene, Epidemiology, and Medical Statistics, Athens University Medical School, Athens, Greece
    J Acquir Immune Defic Syndr 49:492-8. 2008
  9. ncbi Quantitation of human immunodeficiency virus type 1 DNA forms with the second template switch in peripheral blood cells predicts disease progression independently of plasma RNA load
    Leondios G Kostrikis
    Department of Hygiene and Epidemiology, Athens University Medical School, 75 Mikras Asias, 11527 Athens, Greece
    J Virol 76:10099-108. 2002
  10. ncbi Elevated serum levels of soluble immune activation markers are associated with increased risk for death in HAART-naive HIV-1-infected patients
    Nikolaos V Sipsas
    Department of Pathophysiology, Laikon General Hospital and School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
    AIDS Patient Care STDS 17:147-53. 2003

Collaborators

Detail Information

Publications14

  1. ncbi Changes in T cell receptor excision DNA circle (TREC) levels in HIV type 1-infected subjects pre- and post-highly active antiretroviral therapy
    Giota Touloumi
    Department of Hygiene and Epidemiology, Athens University Medical School, Athens, Greece
    AIDS Res Hum Retroviruses 20:47-54. 2004
    ..TREC values, which likely represent a simple indicator of naive T-lymphocyte reserve, may be a clinically useful marker for long-term prognosis of HIV-1 infection and for immune reconstitution after successful HAART...
  2. ncbi Differences in HIV RNA levels before the initiation of antiretroviral therapy among 1864 individuals with known HIV-1 seroconversion dates
    Giota Touloumi
    Department of Hygiene and Epidemiology, Athens Univerity Medical School, Greece
    AIDS 18:1697-705. 2004
    ....
  3. ncbi Highly active antiretroviral therapy interruption: predictors and virological and immunologic consequences
    Giota Touloumi
    Athens University Medical School, Athens, Greece
    J Acquir Immune Defic Syndr 42:554-61. 2006
    ..Further research is needed to investigate the reasons why TI is higher in women. We have identified characteristics of subjects with the greatest risk for CD4 loss in whom TI may have greater risks...
  4. ncbi Differences in HIV natural history among African and non-African seroconverters in Europe and seroconverters in sub-Saharan Africa
    Nikos Pantazis
    Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School, Athens, Greece
    PLoS ONE 7:e32369. 2012
    ..It is unknown whether HIV treatment guidelines, based on resource-rich country cohorts, are applicable to African populations...
  5. ncbi The effect of antiretroviral treatment of different durations in primary HIV infection
    Nikos Pantazis
    Department of Hygiene, Epidemiology and Medical Statistics, Athens University Medical School, Athens, Greece
    AIDS 22:2441-50. 2008
    ....
  6. ncbi Robustness of a parametric model for informatively censored bivariate longitudinal data under misspecification of its distributional assumptions: A simulation study
    Nikos Pantazis
    Department of Hygiene and Epidemiology, Athens University Medical School, Athens, Greece
    Stat Med 26:5473-85. 2007
    ..The proposed model seems robust enough, but its performance on smaller data sets or under more extreme departures of its assumptions needs further investigation...
  7. ncbi Cellular HIV-1 DNA load predicts HIV-RNA rebound and the outcome of highly active antiretroviral therapy
    Angelos E Hatzakis
    Department of Hygiene and Epidemiology, Athens University Medical School, Athens, Greece
    AIDS 18:2261-7. 2004
    ..To assess whether cellular HIV-1 DNA prior to highly active antiretroviral therapy (HAART) initiation predicts its outcome...
  8. ncbi Rates and determinants of virologic and immunological response to HAART resumption after treatment interruption in HIV-1 clinical practice
    Giota Touloumi
    Department of Hygiene, Epidemiology, and Medical Statistics, Athens University Medical School, Athens, Greece
    J Acquir Immune Defic Syndr 49:492-8. 2008
    ..To describe CD4 and HIV RNA changes during treatment resumption (TR) after treatment interruption (TI) compared with response to first highly active antiretroviral therapy (HAART) and to investigate predictors...
  9. ncbi Quantitation of human immunodeficiency virus type 1 DNA forms with the second template switch in peripheral blood cells predicts disease progression independently of plasma RNA load
    Leondios G Kostrikis
    Department of Hygiene and Epidemiology, Athens University Medical School, 75 Mikras Asias, 11527 Athens, Greece
    J Virol 76:10099-108. 2002
    ..This parameter may have important implications for understanding the virological response to combination antiretroviral therapy...
  10. ncbi Elevated serum levels of soluble immune activation markers are associated with increased risk for death in HAART-naive HIV-1-infected patients
    Nikolaos V Sipsas
    Department of Pathophysiology, Laikon General Hospital and School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
    AIDS Patient Care STDS 17:147-53. 2003
    ..Further studies are needed to assess the effect of HAART on the levels of immune activation markers and their prognostic value...
  11. ncbi Periapical status and quality of root canal fillings and coronal restorations in a Greek population
    Maria K Georgopoulou
    Department of Endodontics, Dental School, University of Athens, Athens, Greece
    Quintessence Int 39:e85-92. 2008
    ..To investigate the quality of root canal fillings and coronal restorations in relation to periapical status in a Greek population...
  12. ncbi Changes in the risk of death after HIV seroconversion compared with mortality in the general population
    Krishnan Bhaskaran
    MRC Clinical Trials Unit, 222 Euston Rd, London NW1 2DA, United Kingdom
    JAMA 300:51-9. 2008
    ..Mortality among human immunodeficiency virus (HIV)-infected individuals has decreased dramatically in countries with good access to treatment and may now be close to mortality in the general uninfected population...
  13. ncbi Gender differences in HIV progression to AIDS and death in industrialized countries: slower disease progression following HIV seroconversion in women
    Inmaculada Jarrin
    National Center of Epidemiology, Instituto de Salud Carlos III, Madrid, Spain
    Am J Epidemiol 168:532-40. 2008
    ..74, 95% CI: 0.56, 0.98). Sex differences in HIV disease progression have become larger and statistically significant in the era of highly active antiretroviral therapy, supporting a stronger impact of health interventions among women...
  14. ncbi Slower CD4 cell decline following cessation of a 3 month course of HAART in primary HIV infection: findings from an observational cohort
    Sarah Fidler
    Imperial College, St Mary s Hospital, London, UK
    AIDS 21:1283-91. 2007
    ..To investigate the effect of a short course of HAART during primary HIV infection (PHI) on rate of CD4 cell and viral load change...